(P) INTRODUCTION Flashcards

1
Q

the practice of medicinal chemistry that is devoted to the discovery and development of new drugs

A

Organic Medicinal Chemistry

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

an agent intended for use in the diagnosis, mitigation, treatment, cure, or prevention of disease in humans or in other animals

A

Drug

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

(6) Key Concepts in Drug Action

A
  1. Receptor
  2. Affinity
  3. Intrinsic Activity
  4. Agonist
  5. Antagonist
  6. Allosteric Site
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

• A substance with which a drug interacts to produce a pharmacological response.
• 90% are primarily proteins
• also contain nucleic acids and lipids

A

Receptor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

The drug’s ability to bind to a receptor

A

Affinity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

The drug’s ability to elicit a pharmacologic action upon binding.

A

Intrinsic Activity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Combines affinity and intrinsic activity.

A

Agonist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Only possesses affinity without intrinsic activity.

A

Antagonist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

A site on the receptor other than the main binding site.

A

Allosteric Site

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

4 Fundamental Pathways of Pharmacokinetics

A
  1. Absorption
  2. Distribution
  3. Metabolism
  4. Excretion
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

the transfer of a drug from its site of administration to the systemic circulation (or to the bloodstream)

A

Absorption

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

(8) Factors that influence the absorption/ Transport Mechanism

A

• Chemical structure
• Variation in particle size
• Nature of the crystal form (Amorphous > Crystalline)
• Type of tablet coating
• Blood flow to the absorption site
• Total surface area available for absorption
• Contact time at the absorption surface

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Nature of Crystal Form:
• 100% crystalline (long-acting)

A

Ultra-lente

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Nature of Crystal Form:
• 70% crystalline, 30% amorphous (intermediate)

A

Lente insulin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Nature of Crystal Form:
• 100% amorphous (short-acting)

A

Semi-lente

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

• The fraction of the drug that enters systemic circulation unchanged

A

Bioavailability

17
Q

• 100% bioavailability
• Immediate effect and rapid drug action
• But higher risk of toxicity and side effects

A

Intravenous

18
Q

• The reversible transfer of drugs from the bloodstream to tissues or interstitial fluid.

A

Distribution

19
Q

The reversible transfer of drugs from the bloodstream to tissues or interstitial fluid (small intestine)

A

Distribution

20
Q

• serves as reservoir
• it magnets the drug and slowly releases the drug overtime
• may limit access to certain body compartments
• Prolongs drug duration of action

A

Plasma Protein Binding

21
Q

Protein that binds acidic drugs

22
Q

Protein that binds basic drugs

A

α-1-acid-glycoprotein

23
Q

• converts drugs into polar form, water-soluble products that are readily excretable
• detoxification process but not all the time

A

Metabolism

24
Q

Main site of metabolism

25
• compounds that are inactive in their native form, but are easily metabolized to the active agent
Prodrugs
26
Examples of Prodrugs
• Enalapril to Enalaprilat • Chloramphenicol palmitate to Chloramphenicol • Primidone to Phenobarbital • Phenacetin to Paracetamol
27
• when a drug is partially broken down by the liver before it reaches the bloodstream. • This reduces the amount of active drug available to the body, making some oral/rectal medications less effective • applies to oral/rectal drugs (CYP 450) • Ex: Nitroglycerin
First-pass effect
28
• Primary route is via the kidney (for Low Molecular Weight and Polar drugs). • Other routes include biliary/fecal excretion, breastmilk, and sweat. (for High Molecular Weight and Lipophilic Drugs)
Excretion
29
Water-soluble, easily filtered from blood by the kidney
Low Molecular Weight and Polar drugs
30
Dissolves in fats, oils, and lipids
High Molecular Weight and Lipophilic Drugs
31
Drugs excreted via the bile can be reabsorbed in the intestines.
Enterohepatic Recirculation
32